Dan Whitaker

Dan Whitaker

Auto-generated profile, based on publicly available information

Dan Whitaker

Independent Consultant

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
YYYunjin Yum
Yunjin Yum
Monika KarkiMonika Karki
Monika Karki
DWDan Whitaker
Dan Whitaker
Kshitij KarkiKshitij Karki
Kshitij Karki
RSRatnaa Shakya
Ratnaa Shakya
JLJung-Seok Lee
Jung-Seok Lee
Background/Objectives: Antimicrobial resistance (AMR) surveillance is a cornerstone of national AMR strategies but requires sustained, cross-sectoral financing. While the need for such financing is well recognized, its quantification remains scarce in low- and middle-income countries. This study aimed to estimate the full costs of AMR surveillance across the human health, animal health, and food sectors (2021–2030) in selected facilities in Nepal and generate evidence to inform sustainable financing. Methods: A bottom-up micro-costing approach was used to analyze data from five sites. Costs were adjusted for inflation using projected gross domestic product deflators, and probabilistic sensitivity analyses were conducted to assess uncertainty in laboratory sample volumes under four scenarios. Results: The total cost of AMR surveillance in Nepal was $6.7 million: $3.4 million for human health (50.3% out of the aggregated costs), $2.7 million for animal health (39.8%), and $0.7 million for the food sector (9.9%). Laboratories accounted for >90% of total costs, with consumables and personnel as the main cost drivers. Average cost per sample was $150 (animal), $64 (food), and $6 (human). Conclusions: This study offers the first robust, multi-sectoral 10-year cost estimates of AMR surveillance in Nepal. The findings highlight that sustaining AMR surveillance requires predictable domestic financing, particularly to cover recurrent laboratory operations as donor support declines. These results provide cost evidence to support future budgeting and policy planning toward sustainable, nationally financed AMR surveillance in Nepal.

1 January 2026
Verified
Report
Closed access
TWTimothy David Worth
Timothy David Worth
SFStanley Fenwick
Stanley Fenwick
DWDan Whitaker
Dan Whitaker
TLToby Leslie
Toby Leslie
ACAdrienne Chattoe-Brown
Adrienne Chattoe-Brown
MBManisha Bista
Manisha Bista
AMR is an escalating One Health threat with major implications for human health and animal production. Surveillance data is essential to monitor trends, guide antimicrobial stewardship (AMS), and inform policy and investment decisions. However, animal health AMR surveillance in low- and middle-income countries (LMICs) is resource-intensive, and sustainability beyond donor support remains a central challenge. This report, prepared as the Fleming Fund concludes in 2026, reviews the effectiveness, cost‑efficiency, and sustainability of different animal health AMR surveillance strategies, including farm-based, abattoir, opportunistic, and wastewater sampling. We have explored these questions through case studies carried out in Zambia and Nepal.

1 January 2026
Verified
Report
Closed access
TLToby Leslie
Toby Leslie
TWTimothy David Worth
Timothy David Worth
DWDan Whitaker
Dan Whitaker
HHHeidi Hopkins
Heidi Hopkins
ACAdrienne Chattoe-Brown
Adrienne Chattoe-Brown
Towards a One Health AMR Surveillance System: protocol for active AMR surveillance in commercial broiler and layer chicken populations for the Fleming Fund Grants Programme.

1 January 2026
Verified
Report
Closed access
TWTimothy David Worth
Timothy David Worth
DWDan Whitaker
Dan Whitaker
TLToby Leslie
Toby Leslie
ACAdrienne Chattoe-Brown
Adrienne Chattoe-Brown
HHHeidi Hopkins
Heidi Hopkins
This study has employed a mixed methods approach that combined qualitative data collected during field visits with quantitative programme data, including sample throughput, procurement records, point prevalence surveys of antibiotic prescribing, and cost data (associated with microbiology and AMR surveillance) collected through the Technical Assistance for Data and Evidence Use Regional Grant (TADE Africa) and the Zambia country grant.

1 January 2026
Verified
Report
Closed access
TWTimothy David Worth
Timothy David Worth
DWDan Whitaker
Dan Whitaker
TLToby Leslie
Toby Leslie
ACAdrienne Chattoe-Brown
Adrienne Chattoe-Brown
HHHeidi Hopkins
Heidi Hopkins
This study has employed a mixed methods approach that combined qualitative data collected during field visits with quantitative programme data, including sample throughput, procurement records, point prevalence surveys of antibiotic prescribing, and cost data (associated with microbiology and AMR surveillance) collected through the Technical Assistance for Data and Evidence Use Regional Grant (TADE Africa) and the Zambia country grant.

1 January 2026
Verified
Report
Closed access
TWTimothy David Worth
Timothy David Worth
SFStanley Fenwick
Stanley Fenwick
DWDan Whitaker
Dan Whitaker
TLToby Leslie
Toby Leslie
ACAdrienne Chattoe-Brown
Adrienne Chattoe-Brown
MBManisha Bista
Manisha Bista
AMR is an escalating One Health threat with major implications for human health and animal production. Surveillance data is essential to monitor trends, guide antimicrobial stewardship (AMS), and inform policy and investment decisions. However, animal health AMR surveillance in low- and middle-income countries (LMICs) is resource-intensive, and sustainability beyond donor support remains a central challenge. This report, prepared as the Fleming Fund concludes in 2026, reviews the effectiveness, cost‑efficiency, and sustainability of different animal health AMR surveillance strategies, including farm-based, abattoir, opportunistic, and wastewater sampling. We have explored these questions through case studies carried out in Zambia and Nepal.